Barclays: Don't look for upside in LifePoint

Analysts at Barclays Capital on Friday updated their price targets for most players in the hospital sector. Their views on Community Health Systems and Vanguard Health Systems are constructive: They lifted CHS' target to $36 from $32 — the stock (Ticker: CYH) closed Friday at $32.27 — and gave their Vanguard (Ticker: VHS) target a bump to $16 from $15, leaving investors almost 30 percent of upside. But their outlook for shares of LifePoint Hospitals is nowhere near as rosy. They see the stock (Ticker: LPNT) giving up the gains it has made in the past month and going back to $36 from around $40.

SEE ALSO: Our note on Barclays' initiation of LifePoint last fall with a $44 price target